HWHubert Wróblewski

Hubert Wróblewski

*This is an algorithmically generated author record based on publicly available information.

Hubert Wróblewski has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A 69-year-old patient with Ogilvie’s syndrome –case report

    by Aleksandra Iwona Zimna, Hubert Wróblewski, Kinga Wróblewska, Błażej Tomasz Dziurowicz, Ewelina Zygmunt

    Ogilvie’s syndrome is a rare disease with a relatively high mortality rate (15%). It consists in significant distension of the colon, which is not caused by its obstruction. According to researchers, it usually occurs in patients with severe illness, injury, or after surgery The aim of the...


  • Open Access

    Modern methods of obesity treatment - review of the literature

    by Ewelina Zygmunt-Siembida, Hubert Wróblewska, Aleksandra Zimna, Kinga Wróblewska, Magdalena Kozdra, Laura Piasek, Aleksandra Osińska

    Introduction and aim of the study: Obesity is not only increases the risk of developing other diseases, but is itself a chronic disease. It is characterized by a lack of tendency to spontaneous resolution and a tendency to relapse. The growing number of patients facing obesity and its consequences prompts the search for newer and newer methods of its treatment. The aim of this paper is to discuss modern methods of obesity therapy, aimed at reducing the risk of its consequences, both health, psychological, social and economic. Methods and materials: This literature review is based on articles published in the PubMed database from 2016 to 2023, using the following phrases: "obesity risk factors", "obesity treatment", "diagnosis of obesity", "GLP -1 obesity". State of knowledg: We now know that obesity is a disease that needs to be treated. The goal of therapy is not only to achieve the target body weight, but also to reduce the risk of disease and improve the control of coexisting diseases. Conclusion: Obesity is a disease that requires interdisciplinary treatment based on behavioral therapy including changing the lifestyle to a healthier one, psychological support and pharmacological, and in some cases, surgical treatment.

  • Open Access

    The correlation between Yerba Mate and cancer - a review

    by Kinga Wróblewska, Hubert Wróblewski, Monika Zajączkowska, Bartosz Wójtowicz, Aleksandra Zimna, Ewelina Zygmunt-Siembida, Halina Piecewicz-Szczęsna

    Introduction and objective Yerba Mate (YM) is a popular drink obtained from the dried and ground leaves of the Ilex paraguariens. The beneficial effects of Yerba Mate on the cardiovascular system, lipid-lowering, anti-diabetic, hepatoprotective and stimulating properties are known, however, there are also reports supporting its toxicity, that the consumption of Yerba Mate may predispose to the development of cancer. The purpose of this article is to present and organize information on the correlation between drinking Yerba Mate and cancer. Review methods A review of the available literature was performed by searching the PubMed and Google Scholar databases using the following keywords: Yerba Mate and cancer, Yerba Mate. Abbreviated description of the state of knowledge Substances contained in Yerba Mate have a positive impact on the human body. They exert health-promoting effects, e.g. increasing HDL levels and enhancing the antioxidant effect. A particularly desirable effect of Yerba Mate is its modulating effect on the course of the carcinogenesis process. Current knowledge on this subject is not complete. There are no evidences that substances in Yerba Mate without other risk factors increase the risk of oesophageal cancer. It is worth emphasizing that the properties of the Yerba Mate components are related to the reduction of the development of metastases of other cancers. Summary Despite the carcinogenic PAHs contained in the YM extract, there is no clear evidence that drinking it alone, without taking into account the temperature of the drink, could predispose to the development of esophageal cancer. Many substances found in YM have a beneficial effect on the human body.


  • Open Access

    impact of indoor air pollution on the lung cancer – literature review

    by Anna Korzeniowska, Anna Kozłowska, Marcela Maksymowicz, Piotr Machowiec, Aleksandra Zimna, Hubert Wróblewski, Ilona Gąbka, Weronika Dalamata, Jan Dąbrowski, Karolina Gendek

    Introduction: Lung cancer is the most diagnosed type of cancer and the leading cause of death around the world. The most important risk factor for lung cancer is tobacco smoking. However, there are a lot of other lung cancer risk factors, which include: second-hand smoke exposure, environmental exposures (indoor and outdoor air pollution), occupational exposures, genetic predisposition, and previous lung disease. In this study, we would like to present the actual state of knowledge about the influence of radon as well as other indoor air pollutants on the prevalence of lung cancer. State of knowledge: We analyzed nineteen studies in terms of the impact of indoor air pollution on morbidity and mortality caused by lung cancer. The authors of the included studies agree that both radon and other household air pollution (HAP) increase risk of the lung cancer. HAPs are formed during the combustion of solid fuels (i.e. charcoal, wood). Indoor air pollution can cause in the lungs chronic inflammation, cells damage and their proliferation, depletion of antioxidants, impairment of defense mechanisms, production of reactive oxygen species as well as genetic mutations. Radon, on the other hand, emits alpha radiation, which can affect the respiratory epithelium and produce various cytotoxic and genotoxic effects, which promote carcinogenesis. The risk of lung cancer rises by approximately 6-16% per 100 Bq/m3 increase in long-time average residential radon concentration. Conclusions: Radon and other indoor air pollutants are crucial lung cancer risk factors. It is essential to reduce HAPs production, especially in rural areas, where many people still use coal, wood, or straw for household heating and cooking. Moreover, there are regions where is a need to improve ventilation as well as to switch to clean fuel sources, such as gas and electricity. These activities will contribute to reducing the concentration of HAPs in buildings and decreasing the risk of lung cancer.


  • Open Access

    Gestational diabetes mellitus - pathogenesis, diagnosis, treatment and prognosis

    by Ewelina Zygmuny-Siembida, Hubert Wróblewski, Aleksandra Zimna, Kinga Wróblewska, Magdalena Kozdra, Laura Piasek, Aleksandra Osińska

    Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy. It is characterized by hyperglycemia resulting from impaired tissue sensitivity to insulin secreted by pancreatic beta cells. This is due to the action of hormones secreted by the placenta that oppose insulin. The incidence of gestational diabetes continues to increase, posing many potential risks to both mother and fetus. Importantly, these complications also have a long-term dimension. It has been proven that in adulthood, in children born from pregnancies complicated by gestational diabetes, the risk of developing obesity, type II diabetes and cardiovascular diseases increases. Their mothers are also at a similar risk. The main goal of treatment of gestational diabetes is to achieve normoglycaemia. Appropriate dietary management is recommended, and if this is not sufficient, insulin therapy should be initiated.


  • Open Access

    Should patients with Parkinson’s disease only visit a neurologist’s office? - a narrative review of neuropsychiatric disorders among people with Parkinson’s disease

    by Julita Szarpak, Paulina Drożak, Michał Piwoński, Hubert Wróblewski, Justyna Morylowska-Topolska

    Introduction: Parkinson’s disease is a neurodegenerative disease that is often accompanied by disorders such as depression, psychotic disorders, cognitive disorders, anxiety disorders, sleep disorders, impulse control disorders. The aim of the study was to review the literature and present the characteristics of neuropsychiatric disorders occurring in people suffering from Parkinson’s disease, with the specification of the above-mentioned disorders. Material and method: The literature available on the PubMed platform from 1986 to 2022 was reviewed using the following keywords: Parkinson’s disease, depression, anxiety disorders, psychotic disorders, sleep disorders, cognitive disorders, impulse control disorders. Original studies, reviews, meta-analyzes and internet sources were analyzed. Results: The above-mentioned neuropsychiatric disorders appear with different frequency among people suffering from Parkinson’s disease and occur at different times of its duration or even precede its onset for many years. The non-motor symptoms in the form of depressed mood, energy loss or changes in the rhythm of the day may result in a delay of appropriate therapy and thus in complications. Neuropathological changes in the course of Parkinson’s disease as well as dopaminergic drugs used in its therapy influence the development of neuropsychiatric disorders. Conclusions: In order to avoid misdiagnosis, practitioners should use, e.g. scales intended for patients with Parkinson’s disease. To prevent the consequences of the aforementioned disease entities, methods of early diagnosis, determination of risk factors and standardization of the treatment process must be determined. Consistent care for patients with Parkinson’s disease is significant, not only in the neurological field, but also in the psychiatric one.

  • Open Access

    Histamine intolerance caused by Diamine Oxidase (DAO) deficiency – case report

    by Aleksandra Iwona Zimna, Hubert Wróblewski, Maciej Dubaj, Aleksandra Dembowska, Agnieszka Gawryś, Barbara Skrzydło-Radomańska

    Histamine is a biogenic amine, which occurs naturally in the human body. Histamine can be metabolised with Diamine Oxidase (DAO) Enzyme. It is estimated that in 1% of people, as a result of an imbalance between the supply and degradation of histamine, a condition called histamine intolerance...


  • Open Access

    Modulators of CFTR protein function in the treatment of cystic fibrosis - a literature review

    by Dariusz Chojęta, Monika Mierzwa, Hubert Wróblewski, Aleksandra Zimna, Ewelina Zygmunt, Anna Kozłowska, Katarzyna Łysiak

    Cystic fibrosis (CF) is a multi-system genetic disease with an autosomal recessive inheritance mechanism. The breakthroughs in the therapy of patients with CF turned out to be modulators of CFTR protein function. These small-molecule substances, influencing the basic pathogenetic defect, became a model example of precise targeted therapy, thus showing a significant advantage over symptomatic treatment. For modulators of CFTR protein function, numerous therapeutic benefits have been demonstrated with an acceptable safety profile - improved lung function and reduced frequency of pulmonary exacerbations, reduced hospitalization rate, and disease-related improvement in quality of life. The use of these drugs changes the perception of CF from a fatal pediatric disease significantly shortening the life expectancy of patients into a chronic disease in young adults. The subject of further research interest is the development of alternative therapeutic strategies based on new modulators and gene therapy. The publication is a review of the literature and summarizes the current scientific reports on the effectiveness of the use of modulators of CFTR protein function in the treatment of cystic fibrosis.

  • Open Access

    Risk factors of developing inflammatory bowel diseases

    by Aleksandra Iwona Zimna, Hubert Wróblewski, Dariusz Chojęta, Ewelina Zygmunt, Anna Kozłowska

    Introduction: The pathogenesis of inflammatory bowel disease (IBD) is still unknown. It is known to be multi-factorial. The world is seeing an ever increasing number of new cases of these diseases. Ulcerative colitis and Crohn's disease are the main representatives of inflammatory bowel diseases. Aim: The aim of the study was to analyze risk factors for inflammatory bowel diseases. Materials and methods: The results were obtained on the basis of a questionnaire survey. Results: 95 people took part in the survey aged 16 to 72 years old. 35.8% were men and 64.2% were women. 78% lives in cites, only 22% are rural residents. 56.4% of them suffer from ulcerative colitis and 43.6% from Crohn's disease. 40.4% of respondents smoked cigarettes in the past, but currently only 12.6% are still struggling with the addiction. Only 4 people declare brushing their teeth after each meal. 18 people confirm the presence of NCDH in their families, 19 suffer from other autoimmune diseases at the same time. 2 people from among the respondents - also celiac disease. One person had Salmonella and Shigella infection. Conclusions: Due to the mutual cause-effect relationships between genetic predisposition and the influence of environmental factors, it is currently difficult to state which of the above factors plays a decisive role. Environmental factors that play a role in the etiopathogenesis of IBD include, first and foremost, the intestinal bacterial flora, diet, human environment and smoking. There is a clear tendency for the coexistence of autoimmune diseases in the group of patients with NCJ and a predisposition to the disease in the family. There is also a need to educate patients about the benefits of taking probiotics and taking care of proper eating habits. Key words: inflammatory bowel diseases, risk of developing the disease, irresponsible patient

  • Open Access

    Psychiatric manifestations of rheumatic diseases

    by Hubert Wróblewski, Dariusz Chojęta, Aleksandra Zimna, Ewelina Zygmunt, Anna Kozłowska, Monika Mierzwa, Kinga Wróblewska

    Introduction and purpose of the work: Rheumatic diseases are chronic diseases that cause symptoms in many systems of the human body. Their most common symptoms include pain and symptoms of arthritis, their deformities, fatigue, and malaise. The aim of the article is to present the symptoms and mental disorders occurring in the course of selected rheumatic diseases. State of knowledge: The psychological symptoms are characteristic of systemic lupus erythematosus. Specified is a form of lupus called NSPLE (neuropsychiatric systemic lupus erythematosus), which includes neuropsychiatric symptoms in the course of systemic lupus erythematosus. Psychiatric symptoms are also present in the course of other rheumatic diseases. Neuropsychiatric symptoms may affect up to 80% of patients with primary Sjogren's syndrome, with 50% to 80% ahead of diagnosis. It has been proven that systemic slcerosis causes microvascular damage, which may cause neuropsychiatric symptoms in the form of mood disorders, anxiety and cognitive disorders. In one study, 59% of patients with fibromyalgia experienced mania, which was more than twice as high as in the control group. Summary: In the course of all rheumatic diseases presented by us, there are symptoms and mental disorders. They are often mood, cognitive and sleep disturbances. It should be emphasized that the etiology of psychiatric symptoms is multifactorial.